Cited by 333Stroke Rehabilitation and RecoveryAcute Ischemic Stroke ManagementNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index; 14 of the 233 sources its claims cite were checked for support.

Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation

Open access
Hermann, Dirk M, Chopp, Michael·2012·The Lancet Neurology

Abstract

Recent laboratory findings suggest that it might be possible to promote cerebral plasticity and neurological recovery after stroke by use of exogenous pharmacological or cell-based treatments. Brain microvasculature and glial cells respond in concert to ischaemic stressors and treatment, creating an environment in which successful recovery can ensue. Neurons remote from and adjacent to the ischaemic lesion are enabled to sprout, and neural precursor cells that accumulate with cerebral microvessels in the perilesional tissue further stimulate brain plasticity and neurological recovery. These factors interact in a highly dynamic way, facilitating temporally and spatially orchestrated responses of brain networks. In view of the complexity of the systems involved, stroke treatments that stimulate and amplify these endogenous restorative mechanisms might also provoke unwanted side-effects. In experimental studies, adverse effects have been identified when neurorestorative treatments were administered to animals with severe associated illnesses, after thrombolysis with alteplase, and when therapies were initiated outside appropriate time windows. Balancing the opportunities and possible risks, we provide suggestions for the translation of restorative therapies from the laboratory to the clinic.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(12)70039-x

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

108 Not checked yet · 26 Own interpretation · 14 No basis given · 5 Partly supported · accuracy not yet measured

Verify all 219 references — free account

Show all 91 claims

  • It may state two separate claims as one. 54
  • Probably not a substantial claim. 9
62 of 62
  • The paper relies on this without support.

    The restorative mechanisms observed in animal models are sufficiently similar to those in humans that therapies targeting them could promote human recovery.

    “Promising results from experimental studies have subsequently led to clinical trials,3,7–9 the results of which are eagerly awaited.”
  • The paper relies on this without support.

    Adverse effects seen in experimental animals under specific conditions predict potential adverse effects in human patients.

    “In experimental studies, adverse effects have been identified when neurorestorative treatments were administered to animals with severe associated illnesses, after thrombolysis with alteplase, and when therapies were initiated outside appropriate time windows.”
  • The paper relies on this without support.

    Stroke occurs mainly in later life.

    “Stroke affects human beings mainly in the later stages of life.”
  • The paper relies on this without support.

    Experiments in animals that are otherwise healthy poorly represent comorbidities.

    “Experimental studies poorly mimic comorbidities, because experiments are done mainly in animals that are otherwise healthy.”
  • The paper relies on this without support.

    The effects of hypertension and hypercholesterolaemia on brain remodelling are not fully known.

    “The consequences of both risk factors for brain remodelling are not completely understood.”
  • The paper relies on this without support.

    Most current knowledge comes from laboratory animals, chiefly rodents.

    “Our current knowledge derives largely from laboratory animals, mainly rodents.”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Research works printed but not linked: 1

  1. Cui, 2010, Niacin treatment of stroke increases synaptic plasticity and axon growth in rats, Stroke, 41, 2044, 10.1161/strokeaha.110.589333 · DOI · Paper page

Cited by

Sorted by citations

Items 301–332 of 332

Metadata

Authors
Hermann, D. M., & Chopp, M.
Affiliations
  • Essen University Hospital (DE)
  • Oakland University (US)
Corresponding author
Hermann, Dirk M
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2012-04
Volume
11
Issue
4
Pages
369-380
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2112095855
Cited by
333
References
102
Citations by year
2026: 15 · 2025: 10 · 2024: 15 · 2023: 14 · 2022: 15 · 2021: 21 · 2020: 35 · 2019: 28 · 2018: 24 · 2017: 25 · 2016: 35 · 2015: 33 · 2014: 20 · 2013: 36 · 2012: 7
FWCI
3.90
Type
journal article
Language
en
Open access
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • German Research Foundation ((HE3173/2-1 and HE3173/3-1))
  • National Institutes of Health ((AG037506))
Topics
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
stroke recovery, neuroplasticity, neurorestoration, cell therapy, pharmacotherapy, cerebral microvasculature, glial cells, neural progenitor cells, perilesional tissue, ischemic stroke, alteplase thrombolysis, adverse effects, clinical translation, time window for treatment
MeSH terms
Animals, Neuronal Plasticity, Neovascularization, Physiologic, Stroke, Rats, Neurogenesis, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review